High Life Global is U.S.-based, but the editorial perspective is intentionally international. Cannabis is no longer a topic that can be covered meaningfully through a single-country lens. Reform in Germany affects the broader European conversation. Thailand changed how much of Asia was discussed, even after policy reversals and tighter control. Canada remains a major point of comparison for commercial adult-use markets. Uruguay still matters because of its historical role in legalization. South Africa, Australia, Colombia, and many other jurisdictions shape how reform, medical access, and regulation are discussed around the world.
That global lens matters for a second reason as well: cannabis misinformation often spreads when local assumptions are exported across borders. A policy headline in one country gets treated as universal. A product category legal in one market gets assumed legal everywhere. A decriminalization model gets confused with full legalization. A medical framework gets confused with broad consumer access. High Life Global’s international coverage is built to avoid that kind of flattening and to keep legal and cultural context attached to the information being published.
